Estimating the Probability of Toxicity at the Recommended Dose Following a Phase I Clinical Trial in Cancer

DOI10.2307/2532350zbMath0825.62842OpenAlexW2324021516WikidataQ45253654 ScholiaQ45253654MaRDI QIDQ4696421

John O'Quigley

Publication date: 29 June 1993

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.2307/2532350

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Related Items (6)

A system for determining maximum tolerated dose in clinical trial ⋮ A new design of the continual reassessment method ⋮ Continual reassessment and related dose-finding designs ⋮ Adaptive clinical trial designs for phase I cancer studies ⋮ Theoretical study of the continual reassessment method ⋮ Dose-Finding Designs for HIV Studies

This page was built for publication: Estimating the Probability of Toxicity at the Recommended Dose Following a Phase I Clinical Trial in Cancer